
01/27/2023
In meetings hosted by Nasdaq MarketSite, the company reviewed its drug development programs that fight the opioid crisis through pharmaceuticals that reduce pain without causing addiction.
https://ir.janone.com/news-events/press-releases/detail/48/janone-charts-ambitious-strategic-course-for-non-addictive